Cargando…

Hijacking antibody-induced CTLA-4 lysosomal degradation for safer and more effective cancer immunotherapy

It remains unclear why the clinically used anti-CTLA-4 antibodies, popularly called checkpoint inhibitors, have severe immunotherapy-related adverse effects (irAEs) and yet suboptimal cancer immunotherapeutic effects (CITE). Here we report that while irAE-prone Ipilimumab and TremeIgG1 rapidly direc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yan, Du, Xuexiang, Liu, Mingyue, Tang, Fei, Zhang, Peng, Ai, Chunxia, Fields, James K., Sundberg, Eric J., Latinovic, Olga S., Devenport, Martin, Zheng, Pan, Liu, Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796842/ https://www.ncbi.nlm.nih.gov/pubmed/31267017 http://dx.doi.org/10.1038/s41422-019-0184-1

Ejemplares similares

Uncoupling therapeutic from immunotherapy-related adverse effects for safer and effective anti-CTLA-4 antibodies in CTLA4 humanized mice
por: Du, Xuexiang, et al.
Publicado: (2018)

A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy
por: Du, Xuexiang, et al.
Publicado: (2018)

Anti-CTLA-4 antibodies in cancer immunotherapy: selective depletion of intratumoral regulatory T cells or checkpoint blockade?
por: Tang, Fei, et al.
Publicado: (2018)

CTLA-4 antibody-drug conjugate reveals autologous destruction of B-lymphocytes associated with regulatory T cell impairment
por: Muthana, Musleh M., et al.
Publicado: (2023)

CD24Fc ameliorates immune-related adverse events while preserving anti-tumor therapeutic effect
por: Liu, Mingyue, et al.
Publicado: (2022)

Mechanism- and Immune Landscape-Based Ranking of Therapeutic Responsiveness of 22 Major Human Cancers to Next Generation Anti-CTLA-4 Antibodies
por: Zhang, Peng, et al.
Publicado: (2020)

Autophagy-lysosome inhibitor chloroquine prevents CTLA-4 degradation of T cells and attenuates acute rejection in murine skin and heart transplantation
por: Cui, Jikai, et al.
Publicado: (2020)

Implementing Logic Gates for Safer Immunotherapy of Cancer
por: Savanur, Mohammed Azharuddin, et al.
Publicado: (2021)

Autophagy-lysosome inhibitor chloroquine prevents CTLA-4 degradation of T cells and attenuates acute rejection in murine skin and heart transplantation: Erratum
por: Cui, Jikai, et al.
Publicado: (2022)

Targeting HIF-1α abrogates PD-L1–mediated immune evasion in tumor microenvironment but promotes tolerance in normal tissues
por: Bailey, Christopher M., et al.
Publicado: (2022)

To become a more stronger and safer country
por: Lee, Jong-Koo
Publicado: (2023)

CTLA-4 in Regulatory T Cells for Cancer Immunotherapy
por: Sobhani, Navid, et al.
Publicado: (2021)

Signaling in Effector Lymphocytes: Insights toward Safer Immunotherapy
por: Rajasekaran, Kamalakannan, et al.
Publicado: (2016)

Structure of CTLA-4 complexed with a pH-sensitive cancer immunotherapeutic antibody
por: Gao, Han, et al.
Publicado: (2020)

Automated driving: safer and more efficient future driving
por: Watzenig, Daniel, et al.
Publicado: (2017)

Combination Immunotherapy with 4-1BBL and CTLA-4 Blockade for the Treatment of Prostate Cancer
por: Youlin, Kuang, et al.
Publicado: (2012)

RAGA prevents tumor immune evasion of LUAD by promoting CD47 lysosome degradation
por: Zhang, Lian, et al.
Publicado: (2023)

An Infrastructure to Provide Safer, Higher-Quality, and More Equitable Telehealth
por: Kobeissi, Mahrokh M., et al.
Publicado: (2023)

A decade after Francis: is the NHS safer and more open?
por: Martin, Graham, et al.
Publicado: (2023)

Creating more and more new institutions may not make the world safer from pandemics
por: Wenham, Clare
Publicado: (2023)

Recent research and clinical progress of CTLA-4-based immunotherapy for breast cancer
por: Zhang, Hongsheng, et al.
Publicado: (2023)

Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy
por: Heinzerling, Lucie, et al.
Publicado: (2016)

Toward a More Complete, Flexible, and Safer Speed Planning for Autonomous Driving via Convex Optimization
por: Zhang, Yu, et al.
Publicado: (2018)

Inhibitor Hijacking of Akt Activation
por: Okuzumi, Tatsuya, et al.
Publicado: (2009)

Quercetin Promotes TFEB Nuclear Translocation and Activates Lysosomal Degradation of Ferritin to Induce Ferroptosis in Breast Cancer Cells
por: An, Songbo, et al.
Publicado: (2022)

Crk gets hijacked
por: Van Epps, Heather L.
Publicado: (2005)

Hijacking translation in addiction
por: Izquierdo, Alicia, et al.
Publicado: (2016)

Biogenic pentagonal silver nanoparticles for safer and more effective antibacterial therapeutics
por: Khan, Salman, et al.
Publicado: (2018)

Chiral Cognisance: A Road to Safer and More Effective Medicinal Products
por: Ariëns, E J, et al.
Publicado: (1994)

CTLA4 DNA methylation is associated with CTLA-4 expression and predicts response to immunotherapy in head and neck squamous cell carcinoma
por: Hoffmann, Friederike, et al.
Publicado: (2023)

Triamterene induces autophagic degradation of lysosome by exacerbating lysosomal integrity
por: Park, Na Yeon, et al.
Publicado: (2021)

Tumor hijacks macrophages and microbiota through extracellular vesicles
por: Jiang, Jipeng, et al.
Publicado: (2022)

Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancer
por: Wada, Satoshi, et al.
Publicado: (2013)

Pitfalls of immunotherapy: lessons from a patient with CTLA-4 haploinsufficiency
por: Watson, Leisa Rebecca, et al.
Publicado: (2018)

Leveraging the Treg-intrinsic CTLA4–PKCη signaling pathway for cancer immunotherapy
por: Liu, Hsin-Yu, et al.
Publicado: (2021)

meCLICK-Seq, a Substrate-Hijacking and RNA Degradation Strategy for the Study of RNA Methylation
por: Mikutis, Sigitas, et al.
Publicado: (2020)

Epidemic of care: a call for safer, better and more accountable health care
por: Wognum, Peter
Publicado: (2004)

In silico imaging clinical trials: cheaper, faster, better, safer, and more scalable
por: Badano, Aldo
Publicado: (2021)

Take Control of Audio Hijack
por: McElhearn, Kirk
Publicado: (2015)

Hijackers on the open access highway
por: Watson, Roger
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2v5jofqsvjmdr7sfhtis57adlt